Movie & TV
Past 24 hours
Past 7 days
Past 30 days
Practice Pearl #2 Challenges in Using DOACs in Obese Patients and Education
The panel of experts in cardiology discuss the barriers with treatment of obese patients with DOACs. They also discuss the ...
Hair Loss Treatment May Be Safe for Breast Cancer Survivors
Study shows the recurrence rate was within the expected range for breast cancer survivors receiving spironolactone and those ...
Benchmark Does Not Represent Retail Prices, Research Finds
Although pharmacy benefit managers often use the average wholesale price, results of a new study show the measurement lacks ...
Scientists Predict COVID-19 to Become Seasonal Virus in Near Future
The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with ...
Considerations for Approaching Immunoglobulin Treatment With Each Patient
When treating these diseases, immunoglobulin is effective because of its ability to be used by the immune system to ...
Tip of the Week: Establishing New Services in Niche Areas
This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency ...
Understanding Certified Specialty Pharmacist Credentials, NASP Survey Programs
Having a certified specialty pharmacist (CSP) credential can help applicants get hired and be more impactful in the specialty ...
FDA Approves Expanded Use of CINtec PLUS Cytology Assay for Women Testing Positive for High-Risk HPV
The CINtec PLUS Cytology assay is indicated for women who undergo cervical cancer screening and test positive for high-risk ...
Poll Shows Loneliness Doubled Among Older Adults During First Months of COVID-19
In June 2020, 56% of people over 50 years of age said they sometimes or often felt isolated from others, more than double the ...
PTCE Announces David DeRemer as Keynote Speaker for Virtual Directions in Oncology Pharmacy® 2020 Fall Conference Series
The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for ...
Use of Multiple Sclerosis Disease-Modifying Therapies During COVID-19 Pandemic
In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and ...
FDA Gives Breakthrough Therapy Designation to Myelodysplastic Syndrome Drug
CD47 monoclonal antibody used in combination with azacitidine in treatment-naïve patients with high and very high-risk ...